{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "import igraph as ig\n",
    "\n",
    "sys.path.append(\"/Users/jlq293/Projects/Study-1-Bibliometrics/src/main_path/\")\n",
    "\n",
    "import pandas as pd\n",
    "import networkx as nx"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# load and prep data\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "params = \"alpha0.3_k20_res0.005\"\n",
    "p = f\"../data/06-clustered-df/{params}.pkl\"\n",
    "df = pd.read_pickle(p)\n",
    "\n",
    "# print(df.columns)\n",
    "\n",
    "df_dict = {}\n",
    "for cluster in df[\"cluster_alpha0.3_k20_res0.005\"].unique():\n",
    "    # create df to key and sort by centrality\n",
    "    df_dict[cluster] = df[df[\"cluster_alpha0.3_k20_res0.005\"] == cluster].sort_values(\n",
    "        by=\"centrality_alpha0.3_k20_res0.005\", ascending=False\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Cluster 101\n",
      "Gateways to clinical trials: September 2005\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Randomized Single-Center Study of Effectiveness and Safety of a Resorbable Lysine-Based Urethane Adhesive for a Drain-Free Closure of the Abdominal Donor Site in a DIEP Flap Breast Reconstruction Procedure\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "SECTION K: PHARMACOLOGY\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Gateways to clinical trials\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "Gateways to Clinical Trials\n",
      "# # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # \n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "def cluster_title_print(df_dict, cluster, random=False, n=10):\n",
    "    if random:\n",
    "        titles = df_dict[cluster].sample(n, random_state=1887)[\"title\"].values\n",
    "    else:\n",
    "        titles = df_dict[cluster].head(n)[\"title\"].values\n",
    "    print(f\"Cluster {cluster}\")\n",
    "    for title in titles:\n",
    "        print(title)\n",
    "        print(\"# # \" * 30)\n",
    "    print(\"\\n\")\n",
    "\n",
    "\n",
    "cluster_title_print(df_dict, 101, random=True, n=5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "cluster_labels = {\n",
    "    0: \"ocd\",\n",
    "    1: \"pregnancy\",\n",
    "    2: \"determine drug concentration\",\n",
    "    3: \"chronic unpredictable mild stress in mice\",\n",
    "    4: \"serotinin receptor studies\",\n",
    "    5: \"Cytochrome P450\",\n",
    "    6: \"effect on fish\",\n",
    "    7: \"wastewater\",\n",
    "    8: \"In vivo pregnancy\",\n",
    "    9: \"Drug utilisation\",\n",
    "    10: \"PTSD\",\n",
    "    11: \"sexual dysfunction\",\n",
    "    12: \"fluoxetine; diverse\",\n",
    "    13: \"pediatric depression pharmacotherapy\",\n",
    "    14: \"forced swimming test\",\n",
    "    15: \"pharmacotherapy of depression review\",\n",
    "    16: \"Polymorphism\",\n",
    "    17: \"Serotonin syndrome\",\n",
    "    18: \"Depression treatment in carciovascular pathologies\",\n",
    "    19: \"Paroxetine, diverse\",\n",
    "    20: \"StarD\",\n",
    "    21: \"Pain\",\n",
    "    22: \"post stroke depression\",\n",
    "    23: \"inflammation and serotonin\",\n",
    "    24: \"review of antidepressant medications\",\n",
    "    25: \"weight management\",\n",
    "    26: \"geriatric use of antidepressants\",  # as ads in dementia but also agains agitation\n",
    "    27: \"Brain Derived Neurotrophic Factor\",\n",
    "    28: \"suicide risk\",\n",
    "    29: \"hippocampal neurogenesis\",\n",
    "    30: \"fear\",\n",
    "    31: \"panic disorder\",\n",
    "    32: \"treatment response biomarker\",  # where does this go within pharmacology?\n",
    "    33: \"bleeding risk\",\n",
    "    34: \"natural products\",\n",
    "    35: \"Anxiety\",\n",
    "    36: \"paroxetine binding\",\n",
    "    37: \"fracture risk\",\n",
    "    38: \"cancer\",  # the cluster is on cancer risk as well as protection\n",
    "    39: \"Dermatology\",  # psychosomatic / psychodermatology\n",
    "    40: \"covid\",  # almost exclusively fluvoxamine\n",
    "    41: \"alcoholism\",\n",
    "    42: \"irritable bowel disease\",\n",
    "    43: \"premature ejaculation\",\n",
    "    44: \"analytical chemistry\",  # determine concentration in tablets\n",
    "    45: \"sleep\",\n",
    "    46: \"eating disorders\",\n",
    "    47: \"neuroimaging\",  # uses human, in vivo, and in vitro studies. put it in any?\n",
    "    48: \"parkinson's disease\",\n",
    "    49: \"drug-drug interaction\",\n",
    "    50: \"ssri toxicity\",\n",
    "    51: \"sertraline, diverse\",\n",
    "    52: \"bipolar disorder\",\n",
    "    53: \"affective effects\",\n",
    "    54: \"fluvoxamine\",\n",
    "    55: \"hot flushes (menopause)\",\n",
    "    56: \"diabetes\",  # both as side effect and depression management in special pop\n",
    "    57: \"autoreceptors\",  # rather unclear to me\n",
    "    58: \"neuroendocrine system\",  # mixed study subjects (human, animal, in vitro)\n",
    "    59: \"cocaine addiction\",\n",
    "    60: \"venlafaxine for depression\",\n",
    "    61: \"schizophrenia\",\n",
    "    62: \"extrapyramidal side effects\",  #  movement dysfunctions\n",
    "    63: \"anxiety\",  # check merge with 35\n",
    "    64: \"clinical pharmacogenetics\",\n",
    "    65: \"synthesis and production\",\n",
    "    66: \"escitalopram for depression\",\n",
    "    67: \"epilepsy\",  # special pop and induced seizures\n",
    "    68: \"pediatric drug utilisation\",  # check merge with 9\n",
    "    69: \"autism\",\n",
    "    70: \"premenstrual syndromes\",\n",
    "    71: \"QT prolongation\",\n",
    "    72: \"chronic/prolonged use\",\n",
    "    73: \"pharmacoeconomics/health economics\",\n",
    "    74: \"ion channels\",\n",
    "    75: \"MDMA\",\n",
    "    76: \"cognitive function\",\n",
    "    77: \"serotonin transporter\",\n",
    "    78: \"pulmonary hypertension\",\n",
    "    79: \"citalopram\",\n",
    "    80: \"synthesis and compounds?\",  # need help here\n",
    "    81: \"enantiomer of citalopram\",  # someonee help me here (analyze pharmaceutical formulations in vitro to assess the composition and concentration of citalopram and its metabolites.?)\n",
    "    82: \"hyponatremia\",  # low sodium in blood\n",
    "    83: \"geriatric depression treatment\",\n",
    "    84: \"sertraline diverse\",\n",
    "    85: \"comparative studies\",\n",
    "    86: \"hepatic effects\",  # (on the liver)\n",
    "    87: \"borderline personality disorder\",\n",
    "    88: \"compulsions? body dysmorphic disorder? \",\n",
    "    89: \"gut microbiota\",\n",
    "    90: \"withdrawal symptoms\",\n",
    "    91: \"drug quantification (sertraline)\",\n",
    "    92: \"lactation\",  # put in pregnancy category?\n",
    "    93: \"pediatric anxiety\",\n",
    "    94: \"Neurosteroids\",\n",
    "    95: \"astrocytic receptors\",\n",
    "    96: \"Neurological Disorders and Emotional Dysregulation\",\n",
    "    97: \"male fertility\",  # testicular tissue and sperm quality\n",
    "    98: \"vitamin supplements for depression\",  # folic acid\",vitamin B12 and B9\n",
    "    99: \"seasonal affective disorder\",  # light therapy\n",
    "    100: \"safety reviews\",\n",
    "    101: \"gateway to clinical trials\",  # has lots of garbage\n",
    "    102: \"fibromyalgia\",  # merge with pain? (widespread musculoskeletal pain, fatigue, sleep disturbances, cognitive difficulties)\n",
    "    103: \"ssri reviews\",  # lots of garbage\n",
    "    104: \"marbe burying test\",  # animal model for anxiety\n",
    "    105: \"vilazodone for depression\",\n",
    "    106: \"depression in cancer patients\",\n",
    "    107: \"lipid metabolism\",  # in vivo and vitro studies, some human, what now?\n",
    "    108: \"neurotrophic factors, clinical\",  # (like bdnf); biomarker?\n",
    "    109: \"Loudness Dependence of Auditory Evoked Potentials (LDAEP)\",  # bit of garbage # garbage of depression response?\n",
    "    110: \"headache\",  # migraine and tension\n",
    "    111: \" stress urinary incontinence (SUI)\",\n",
    "    112: \"st johns worth\",\n",
    "    113: \"ssris\",  # no abstracts, ssri only\n",
    "    114: \"depression in renal disease\",\n",
    "    115: \"glaucoma risk\",\n",
    "    116: \"agomelatine for depression\",\n",
    "    117: \"acupuncture for depression\",\n",
    "    118: \"neuropsychiatric disorders\",  # , including catatonia, Tourette's syndrome\n",
    "    119: \"hypothermia\",\n",
    "    120: \"galanin system\",\n",
    "    121: \"recurrent depression\",\n",
    "    122: \"dysthymia\",\n",
    "    123: \"generic drugs\",\n",
    "    124: \"trichoillomania\",\n",
    "    125: \"addictions\",  # gambling mainly # merge with above to \"behavioral disorders?  \"\n",
    "    126: \"mania risk\",\n",
    "    127: \"zinc and depression\",\n",
    "    128: \"traumatic brain injury (TBI)\",\n",
    "    129: \"Galactorrhea\",  # breasts leak milk\n",
    "    130: \"Syncope\",  # fainting; treatment\n",
    "    131: \"exercise and depression\",\n",
    "    132: \"sigma 1 receptor\",  # is this in vivo?\n",
    "    133: \"critical psychiatry\",\n",
    "    134: \"G protein\",  # -coupled receptor kinase 2 (GRK2) inhibitors\", #  therapeutic applications in cardiovascular diseases, inflammation, and other related. NEEDS CHECK\n",
    "    135: \"hepatitis C\",  # special pop\n",
    "    136: \"thyroid levels\",  # as risk and as adjunct treatment\n",
    "    137: \"oral cavity\",  # burning mouth syndrome\n",
    "    138: \"depression in HIV\",  # special pop\n",
    "    139: \"veterinary use\",  # dogs mostly\n",
    "    140: \"electric current therapy\",  # electroconvulsive therapy\n",
    "    141: \"olfactory bulbectomy\",  # Researchers use this model to investigate the underlying neurobiological mechanisms of depression and to test potential antidepressant treatments.\n",
    "    142: \"excitatory/inhibitory effects\",\n",
    "    143: \"multiple sclerosis\",  # special pop and impact on ms\n",
    "    #############################\n",
    "    # form here less than 50 papers\n",
    "    #############################\n",
    "    144: \"neurotransmitter release estimation\",  # in vivo\n",
    "    145: \"restless legs syndrome\",  # treatment\n",
    "    146: \"chronic obstructive pulmonary disease (COPD)\",  # special pop\n",
    "    147: \"mutism\",\n",
    "    148: \"tryptophan metabolism\",  #\n",
    "    149: \"Congenital myasthenic syndromes\",\n",
    "    150: \"reboxetine for depression\",\n",
    "    151: \"escitalopram, diverse\",  # no abstracts, garbage.\n",
    "    152: \"statins for depression\",\n",
    "    153: \"blood brain barrier\",  #\n",
    "    154: \"animal neuroscience\",  # unclear\n",
    "    155: \"hormonal fluctuations\",\n",
    "    156: \"Gastroprotective Effects\",\n",
    "    157: \"too few\",\n",
    "    158: \"too few\",\n",
    "    159: \"too few\",\n",
    "    160: \"too few\",\n",
    "}\n",
    "\n",
    "# save to json\n",
    "import json\n",
    "\n",
    "path = f\"../output/cluster-qualifications/cluster_labels_{params}.json\"\n",
    "\n",
    "with open(path, \"w\") as f:\n",
    "    json.dump(cluster_labels, f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['Pharmacology', 'Disorder/Disease', 'Safety', 'Study type', 'Special Populations', 'Drug', 'Other'])"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cluster_tree = {\n",
    "    \"Pharmacology\": {\n",
    "        \"Pharmacokinetics\": {\n",
    "            \"Analytical Methods\": [2, 44, 81, 91],\n",
    "            \"Cytochromes\": [5],\n",
    "            \"blood brain barrier\": [153],\n",
    "        },\n",
    "        \"Pharmacodynamics\": {\n",
    "            \"Metabolism\": [],\n",
    "            \"Mechanism of Action\": {\n",
    "                \"Receptor studies\": [4, 36, 57],\n",
    "                \"Animal models\": [3, 14],\n",
    "                \"hippocampal neurogenesis\": [29],\n",
    "                \"neuroimaging\": [47],\n",
    "                \"neuroendocrine system\": [47],\n",
    "                \"ion channels\": [74],\n",
    "                \"serotonin transporter\": [77],\n",
    "                \"synthesis and compounds?\": [80],\n",
    "                \"gut microbiota\": [89],\n",
    "                \"neurosteroids\": [94],\n",
    "                \"astrocytic receptors\": [95],\n",
    "                \"lipid metabolism\": [107],\n",
    "                \"neurotrophic factors\": [108],\n",
    "                \"Loudness Dependence of Auditory Evoked Potentials (LDAEP)\": [109],\n",
    "                \"galanin system\": [120],\n",
    "                \"sigma 1 receptor\": [132],\n",
    "                \"ofaction bulbectomy\": [141],\n",
    "                \"tryptophan metabolism\": [148],\n",
    "            },\n",
    "            \"inflammation\": [23],\n",
    "            \"fear\": [30],\n",
    "            \"prolonged use\": [72],\n",
    "            \"pulmonary hypertension\": [78],\n",
    "            \"male fertility\": [97],\n",
    "            \"G protein\": [134],\n",
    "            \"excitatory/inhibitory effects\": [142],\n",
    "            \"neurotransmitter release estimation\": [144],\n",
    "            \"animal neuroscience\": [154],\n",
    "            \"hormonal fluctuations\": [155],\n",
    "        },\n",
    "        \"Pharmacogenetics\": {\n",
    "            \"Polymorphism\": [16],\n",
    "            \"BDNF\": [27],\n",
    "            \"clinical pharmacogenetics\": [64],\n",
    "        },\n",
    "        \"Pharmacoepidemiology\": {\"Drug utilisation\": [9, 68]},\n",
    "        \"Review\": {\"Review of antidepressant medications\": [24]},\n",
    "    },\n",
    "    \"Disorder/Disease\": {\n",
    "        \"Depression\": [\n",
    "            3,\n",
    "            13,\n",
    "            15,\n",
    "            16,\n",
    "            18,\n",
    "            20,\n",
    "            22,\n",
    "            28,\n",
    "            32,\n",
    "            60,\n",
    "            64,\n",
    "            66,\n",
    "            73,\n",
    "            83,\n",
    "            85,\n",
    "            98,\n",
    "            105,\n",
    "            106,\n",
    "            112,\n",
    "            116,\n",
    "            117,\n",
    "            121,\n",
    "            122,\n",
    "            123,\n",
    "            127,\n",
    "            128,\n",
    "            131,\n",
    "            135,\n",
    "            136,\n",
    "            138,\n",
    "            140,\n",
    "            146,\n",
    "            150,\n",
    "            152,\n",
    "        ],\n",
    "        \"Anxiety\": [30, 35, 63, 93],\n",
    "        \"OCD\": [0],\n",
    "        \"PTSD\": [10],\n",
    "        \"Panic Disorder\": [31],\n",
    "        \"Pain\": [21],\n",
    "        \"Inflammations\": [23, 134],\n",
    "        \"Weight Management\": [25],\n",
    "        \"Agitation in dementia\": [26],\n",
    "        \"Dermatology\": [39],\n",
    "        \"Covid\": [40],\n",
    "        \"alcohol dependence\": [41],\n",
    "        \"irretable bowel disease\": [42],\n",
    "        \"premature ejaculation\": [43],\n",
    "        \"sleep\": [45],\n",
    "        \"eating disorders\": [46],\n",
    "        \"bipolar disorder\": [46],\n",
    "        \"hot flushes\": [55],\n",
    "        \"diabetes\": [56],\n",
    "        \"cocaine addiction\": [59],\n",
    "        \"schizophrenia\": [61],\n",
    "        \"epilepsy\": [67],\n",
    "        \"autism\": [69],\n",
    "        \"premenstrual syndromes\": [70],\n",
    "        \"Borderline Personlaity Disorder\": [87],\n",
    "        \"Neurological Disorders\": [96],\n",
    "        \"seasonal affective disorder\": [99],\n",
    "        \"fibromyalgia\": [102],\n",
    "        \"headache\": [110],\n",
    "        \"renal disease\": [114],\n",
    "        \"neuropsychiatric disorders\": [118],\n",
    "        \"addictions\": [125],\n",
    "        \"trichotillomania\": [124],\n",
    "        \"traumatic brain injury\": [128],\n",
    "        \"syncope\": [130],\n",
    "        \"cardiovascular diseases\": [134],\n",
    "        \"oral cavity\": [137],\n",
    "        \"multiple sclerosis\": [143],\n",
    "        \"mutism\": [147],\n",
    "        \"Congenital myasthenic syndromes\": [149],\n",
    "        \"gastroprotective effects\": [156],\n",
    "    },\n",
    "    \"Safety\": {  # or pharmacovigilance?\n",
    "        \"Serotonin syndrom\": [17],\n",
    "        \"Sexual dysfunction\": [11],\n",
    "        \"Suicide\": [13, 28],\n",
    "        \"Bleeding\": [33],\n",
    "        \"Fracture\": [37],\n",
    "        \"Cancer\": [38],\n",
    "        \"SSRI Toxicity\": [50],\n",
    "        \"diabetes\": [56],\n",
    "        \"extrapyramidal side effects\": [62],\n",
    "        \"qt prolongation\": [71],\n",
    "        \"prolonged use\": [72],\n",
    "        \"hyponatremia\": [82],\n",
    "        \"hepatic effects\": [86],\n",
    "        \"withdrawal\": [86],\n",
    "        \"male fertility\": [97],\n",
    "        \"safety reviews\": [100],\n",
    "        \"stress urinary incontinence\": [111],\n",
    "        \"glaucoma risk\": [115],\n",
    "        \"mania\": [126],\n",
    "        \"Galactorrhea\": [129],\n",
    "        \"restless legs syndrom\": [145],\n",
    "    },\n",
    "    \"Study type\": {\n",
    "        \"Clinical Focus\": [\n",
    "            0,\n",
    "            1,\n",
    "            10,\n",
    "            11,\n",
    "            13,\n",
    "            16,\n",
    "            17,\n",
    "            18,\n",
    "            20,\n",
    "            21,\n",
    "            22,\n",
    "            23,\n",
    "            24,\n",
    "            25,\n",
    "            26,\n",
    "            28,\n",
    "            31,\n",
    "            32,\n",
    "            33,\n",
    "            35,\n",
    "            37,\n",
    "            38,\n",
    "            39,\n",
    "            41,\n",
    "            43,\n",
    "            45,\n",
    "            46,\n",
    "            48,\n",
    "            49,\n",
    "            50,\n",
    "            54,\n",
    "            55,\n",
    "            56,\n",
    "            60,\n",
    "            61,\n",
    "            62,\n",
    "            63,\n",
    "            64,\n",
    "            66,\n",
    "            67,\n",
    "            68,\n",
    "            69,\n",
    "            71,\n",
    "            76,\n",
    "            79,\n",
    "            82,\n",
    "            83,\n",
    "            84,\n",
    "            85,\n",
    "            86,\n",
    "            87,\n",
    "            90,\n",
    "            92,\n",
    "            93,\n",
    "            96,\n",
    "            98,\n",
    "            100,\n",
    "            102,\n",
    "            103,\n",
    "            105,\n",
    "            108,\n",
    "            109,\n",
    "            110,\n",
    "            112,\n",
    "            113,\n",
    "            114,\n",
    "            116,\n",
    "            117,\n",
    "            118,\n",
    "            121,\n",
    "            122,\n",
    "            123,\n",
    "            124,\n",
    "            125,\n",
    "            128,\n",
    "            130,\n",
    "            131,\n",
    "            135,\n",
    "            136,\n",
    "            137,\n",
    "            138,\n",
    "            140,\n",
    "            143,\n",
    "            145,\n",
    "            146,\n",
    "            147,\n",
    "            148,\n",
    "            149,\n",
    "            150,\n",
    "            152,\n",
    "        ],\n",
    "        \"Preclinical Focus\": {\n",
    "            \"animal models of disorders\": {\n",
    "                \"chronic unpredictable mild stress\": [3],\n",
    "                \"forced swimming test\": [14],\n",
    "                \"marble burying test (anxiety, ocd)\": [104],\n",
    "                \"ofaction bulbectomy\": [141],\n",
    "            },\n",
    "            \"in vivo\": [\n",
    "                4,\n",
    "                5,\n",
    "                8,\n",
    "                21,\n",
    "                27,\n",
    "                29,\n",
    "                30,\n",
    "                34,\n",
    "                36,\n",
    "                57,\n",
    "                59,\n",
    "                72,\n",
    "                75,\n",
    "                77,\n",
    "                78,\n",
    "                89,\n",
    "                94,\n",
    "                97,\n",
    "                99,\n",
    "                104,\n",
    "                119,\n",
    "                120,\n",
    "                127,\n",
    "                141,\n",
    "                142,\n",
    "                144,\n",
    "                153,\n",
    "                154,\n",
    "                156,\n",
    "            ],\n",
    "            \"in vitro\": [44, 74, 81, 91],\n",
    "        },\n",
    "        \"Environmental Focus\": {\n",
    "            \"Fish\": [6],\n",
    "            \"Wastewater\": [7],\n",
    "        },\n",
    "        \"Reviews\": [\n",
    "            15,\n",
    "            24,\n",
    "            35,\n",
    "            51,\n",
    "            52,\n",
    "            55,\n",
    "            60,\n",
    "            63,\n",
    "            66,\n",
    "            68,\n",
    "            69,\n",
    "            76,\n",
    "            79,\n",
    "            83,\n",
    "            84,\n",
    "            85,\n",
    "            87,\n",
    "            90,\n",
    "            92,\n",
    "            93,\n",
    "            100,\n",
    "            103,\n",
    "            106,\n",
    "            110,\n",
    "            113,\n",
    "            150,  # can things be in reviews and in clinical?\n",
    "        ],\n",
    "        \"Comparative studies\": [20, 54],\n",
    "    },\n",
    "    \"Special Populations\": {\n",
    "        \"pregnancy\": [1, 8, 92],  # 92 is lactation\n",
    "        \"pediatrics\": [13, 28, 93],\n",
    "        \"cardiovascular pathologies\": [18],\n",
    "        \"post stroke\": [22],\n",
    "        \"geriatrics\": [\n",
    "            26,\n",
    "            37,\n",
    "            48,\n",
    "            49,\n",
    "            76,\n",
    "            82,  # mainly on a side effect that is more common in elderly\n",
    "            83,\n",
    "            111,\n",
    "        ],\n",
    "        \"diabetes\": [56],\n",
    "        \"cancer\": [106],\n",
    "        \"renal disease\": [114],\n",
    "        \"hepatitis C\": [135],\n",
    "        \"HIV\": [138],\n",
    "        \"chronic obstructive pulmonary disease\": [146],\n",
    "    },\n",
    "    \"Drug\": {\n",
    "        \"Fluoxetine\": [12],\n",
    "        \"Paroxetine\": [19, 36],\n",
    "        \"Sertraline\": [51, 84],\n",
    "        \"Fluvoxamine\": [54],\n",
    "        \"Citalopram\": [79],\n",
    "        \"Escitalopram\": [66, 151],\n",
    "        \"Venlafaxine\": [60],\n",
    "        \"Vilazodone\": [105],\n",
    "        \"Agomelatine\": [116],\n",
    "        \"reboxetine\": [150],\n",
    "        \"statins\": [152],\n",
    "    },\n",
    "    \"Other\": {\n",
    "        \"Natural Products\": [34],\n",
    "        \"affective effects\": [53],\n",
    "        \"synthesis and production\": [65],\n",
    "        \"health economics\": [73, 123],\n",
    "        \"st johns wort\": [112],\n",
    "        \"critical psychiatry\": [133],\n",
    "        \"veterinary use\": [139],\n",
    "    },\n",
    "}\n",
    "\n",
    "\n",
    "with open(f\"../output/cluster-qualifications/cluster_tree_{params}.json\", \"w\") as f:\n",
    "    json.dump(cluster_tree, f)\n",
    "\n",
    "cluster_tree.keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['Depression', 'Anxiety', 'OCD', 'PTSD', 'Panic Disorder', 'Pain', 'Inflammations', 'Weight Management', 'Agitation in dementia', 'Dermatology', 'Covid', 'alcohol dependence', 'irretable bowel disease', 'premature ejaculation', 'sleep', 'eating disorders', 'bipolar disorder', 'hot flushes', 'diabetes', 'cocaine addiction', 'schizophrenia', 'epilepsy', 'autism', 'premenstrual syndromes', 'Borderline Personlaity Disorder', 'Neurological Disorders', 'seasonal affective disorder', 'fibromyalgia', 'headache', 'renal disease', 'neuropsychiatric disorders', 'addictions', 'trichotillomania', 'traumatic brain injury', 'syncope', 'cardiovascular diseases', 'oral cavity', 'multiple sclerosis', 'mutism', 'Congenital myasthenic syndromes', 'gastroprotective effects'])"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cluster_tree[\"Disorder/Disease\"].keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "chronic unpredictable mild stress in mice\n",
      "[('Disorder/Disease', 'Depression')]\n"
     ]
    }
   ],
   "source": [
    "# find all tree branches for a given cluster\n",
    "def find_branches(cluster, tree, cluster_labels):\n",
    "    print(cluster_labels[cluster])\n",
    "    branches = []\n",
    "    for branch, subbranches in tree.items():\n",
    "        if isinstance(subbranches, dict):\n",
    "            for subbranch, clusters in subbranches.items():\n",
    "                if cluster in clusters:\n",
    "                    branches.append((branch, subbranch))\n",
    "        else:\n",
    "            if cluster in subbranches:\n",
    "                branches.append(branch)\n",
    "    print(branches)\n",
    "    return branches\n",
    "\n",
    "\n",
    "branches = find_branches(3, cluster_tree, cluster_labels)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('Disorder/Disease', 'Depression')]"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "branches"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Category Building :\n",
    "\n",
    "## Pharmacology\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. Pharmacokinetics\n",
    "2. Pharmacodynamics\n",
    "   1. Forced Swimming Test\n",
    "3. Pharmacogenetics\n",
    "4. Toxicology?\n",
    "5. Pharmacoepidemiology?\n",
    "\n",
    "## Treatment in Special Populations\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. Pregnant women\n",
    "2. Children\n",
    "3. Elderly\n",
    "4. Disease states (e.g. renal failure, diabetes, cancer, parkinsons, etc.)\n",
    "\n",
    "## Disorders/Diseases (can also be interpreted as expansion of indication)\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. Depression\n",
    "2. Anxiety\n",
    "3. Schizophrenia\n",
    "4. Bipolar disorder\n",
    "5. OCD\n",
    "6. Pain\n",
    "7. Sleep\n",
    "\n",
    "## Drug Focused\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. Fluoxetine\n",
    "2. Sertraline\n",
    "   etc\n",
    "\n",
    "## Animal Focused\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. chronic unpredictable mild stress in mice\n",
    "2. forced swimming test\n",
    "\n",
    "## Safety\n",
    "\n",
    "### Subcategories:\n",
    "\n",
    "1. Bleeding\n",
    "2. Cardiac\n",
    "3. Withdrawal\n",
    "\n",
    "# Open Questions:\n",
    "\n",
    "1. How to deal with non-exclusive categories?\n",
    "\n",
    "   1.1 Multiple categories per paper?\n",
    "\n",
    "2. Using all clusters?\n",
    "3. Merging some clusters?\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Study1Analysis",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
